Sporadic In Utero Generalized Edema Caused by Mutations in the Lymphangiogenic Genes VEGFR3 and FOXC2

Journal of Pediatrics

Volumn 155, Issue 1, 2009, Pages 90-93

  Ghalamkarpour, Arash ^a   Debauche, Christian ^b   Haan, Eric ^c,d   Van Regemorter, Nicole ^e   Sznajer, Yves ^e,f   Thomas, Dominique ^g   Revencu, Nicole ^a   Gillerot, Yves ^b   Boon, Laurence M ^a,b   Vikkula, Miikka ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e ERASME HOSPITAL   (Belgium)

^f UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^g IRIS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SOX18; VASCULOTROPIN RECEPTOR 3;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FETUS HYDROPS; HETEROZYGOSITY; HUMAN; LYMPHEDEMA; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PERIPHERAL EDEMA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

ADULT; CHILD; CODON, NONSENSE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC SCREENING; HUMANS; HYDROPS FETALIS; INFANT; MALE; MUTATION, MISSENSE; PREGNANCY; SOXF TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 67649803011     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.02.023     Document Type: Article

References (21)

1. Boyd P.A., and Keeling J.W. Fetal hydrops. J Med Genet 29 (1992) 91-97
2. Abrams M.E., Meredith K.S., Kinnard P., and Clark R.H. Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics 120 (2007) 84-89
3. Fang J., Dagenais S.L., Erickson R.P., Arlt M.F., Glynn M.W., Gorski J.L., et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67 (2000) 1382-1388
4. Irrthum A., Karkkainen M.J., Devriendt K., Alitalo K., and Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67 (2000) 295-301
5. Karkkainen M.J., Ferrell R.E., Lawrence E.C., Kimak M.A., Levinson K.L., McTigue M.A., et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25 (2000) 153-159
6. Irrthum A., Devriendt K., Chitayat D., Matthijs G., Glade C., Steijlen P.M., et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 72 (2003) 1470-1478
7. Daniel-Spiegel E., Ghalamkarpour A., Spiegel R., Weiner E., Vikkula M., Shalev E., et al. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Prenat Diagn 25 (2005) 1015-1018
8. Ghalamkarpour A., Morlot S., Raas-Rothschild A., Utkus A., Mulliken J.B., Boon L.M., et al. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations. Clin Genet 70 (2006) 330-335
9. Sunyaev S., Ramensky V., Koch I., Lathe III W., Kondrashov A.S., and Bork P. Prediction of deleterious human alleles. Hum Mol Genet 10 (2001) 591-597
10. Thomas P.D., Campbell M.J., Kejariwal A., Mi H., Karlak B., Daverman R., et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13 (2003) 2129-2141
11. Boon L.M., Brouillard P., Irrthum A., Karttunen L., Warman M.L., Rudolph R., et al. A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. Am J Hum Genet 65 (1999) 125-133
12. Evans A.L., Bell R., Brice G., Comeglio P., Lipede C., Jeffery S., et al. Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema. J Med Genet 40 (2003) 697-703
13. Carver C., Brice G., Mansour S., Ostergaard P., Mortimer P., and Jeffery S. Three children with Milroy disease and de novo mutations in VEGFR3. Clin Genet 71 (2007) 187-189
14. Lyon M.F., and Glenister P.H. Chylous ascites (Chy). Mouse News Lett 71 (1984) 26
15. Karkkainen M.J., Saaristo A., Jussila L., Karila K.A., Lawrence E.C., Pajusola K., et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 98 (2001) 12677-12682
16. Brice G., Child A.H., Evans A., Bell R., Mansour S., Burnand K., Sarfarazi M., Jeffery S., and Mortimer P. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet 42 (2005) 98-102
17. Sholto-Douglas-Vernon C., Bell R., Brice G., Mansour S., Sarfarazi M., Child A.H., et al. Lymphoedema-distichiasis and FOXC2: unreported mutations, de novo mutation estimate, families without coding mutations. Hum Genet 117 (2005) 238-242
18. Erickson R.P., Dagenais S.L., Caulder M.S., Downs C.A., Herman G., Jones M.C., et al. Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J Med Genet 38 (2001) 761-766
19. Finegold D.N., Kimak M.A., Lawrence E.C., Levinson K.L., Cherniske E.M., Pober B.R., et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 10 (2001) 1185-1189
20. Brice G., Mansour S., Bell R., Collin J.R., Child A.H., Brady A.F., et al. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 39 (2002) 478-483
21. McCoy M.C., Katz V.L., Gould N., and Kuller J.A. Non-immune hydrops after 20 weeks' gestation: review of 10 years' experience with suggestions for management. Obstet Gynecol 85 (1995) 578-582